tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
Holding PCRX?
Track your performance easily

Pacira Pharmaceuticals (PCRX) Stock Investors

354 Followers
Based on 774,447 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PCRX
On average, investors allocate 0.00% of their portfolios to PCRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 774,447 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PCRX

0.4%
Last 7
Days
4.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PCRX, out of 774,447 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PCRX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
2.78%
$17.13
Increased
0.02%
$20.00
Based on the activity of 14,800 investors who made their portfolios public
The table shows changes in PCRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PCRX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.17%
-1.37%
-2.69%
35.12B
Consumer Cyclical
JD
5.00%
-0.21%
+2.39%
59.05B
Consumer Cyclical
Bristol-Myers Squibb
3.41%
-1.11%
-1.84%
113.13B
Healthcare
CVS Health
3.83%
+0.60%
-4.32%
62.13B
Healthcare
Plug Power
5.23%
-0.14%
-2.78%
2.21B
Industrials
Block
4.21%
+1.18%
+3.36%
57.01B
Technology
Trade Desk
4.80%
-0.08%
-1.38%
65.36B
Technology
ServiceNow
4.03%
+0.17%
+0.21%
230.95B
Technology
Merck & Company
3.34%
+0.21%
+0.25%
258.02B
Healthcare
Target
3.96%
-1.10%
+8.99%
61.64B
Consumer Defensive
Based on the activity of 774,447 active portfolios
Open your Smart Portfolio

PCRX Investor Analysis

PCRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
20.0%
of PCRX holders
are under 35
Average Segment Performance
Average P/E Ratio31.68
Beta11.04
Dividend Yield194.55%
PCRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
44.0%
of PCRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio28.42
Beta21.20
Dividend Yield87.23%
PCRX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.0%
of PCRX holders
are over 55
Average Segment Performance
Average P/E Ratio26.67
Beta9.52
Dividend Yield151.99%
Overview of age group and performance of PCRX stock investors
See who invests in PCRX according to age group and performance.

FAQ

How many retail Investors hold PCRX?
<0.1% of TipRanks' retail investors hold PCRX in their portfolios.
    What is PCRX Investor Sentiment?
    PCRX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of PCRX in the last 7 days?
      ▲ 0.4% of TipRanks' retail investors changed their holding of PCRX in the last 7 days.
        What percentage of retail investors changed their holding of PCRX in the last 30 days?
        ▼ 4.7% of TipRanks' retail investors changed their holding of PCRX in the last 30 days.
          What is the average age of retail investors who hold PCRX?
          The average age of PCRX Holders is between 35–55.
            What other stocks have PCRX investors also bought?
            PCRX Investors also bought DKNG, JD, BMY, CVS, PLUG, SQ, TTD, NOW, MRK, TGT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BIIBBiogen
              BMRNBioMarin Pharmaceutical
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis